Literature DB >> 375964

Modification of the immunogenicity and antigenicity of rat hepatoma cells. II. Mild heat treatment.

R G Dennick, M R Price, R W Baldwin.   

Abstract

I.p. immunization with gamma-irradiated hepatoma cells induces resistance to s.c. tumour-cell challenge in syngeneic WAB/Not rats. Mild heat treatment of these cells (greater than 41 degrees C for 30 min) destroyed this immunoprotective effect, but did not abolish tumour-specific antibody production in treated rats. The binding of syngeneic and alloantibodies to surface antigens expressed on hepatoma cells was unaffected by heat treatment. Thus, heat-treated gamma-irradiated hepatoma cells retain a serologically defined tumour-specific antigen but are unable to elicit immunoprotection. By examining the incorporation of radioactive precursors into DNA, RNA and protein in heat-treated cells, it was determined that above 41 degrees C there was a significant decrease in metabolic activity. It is postulated that for the effective induction of transplantation immunity to tumours, tumour-specific antigens should be present on the surface membranes of a metabolically active cell. This hypothesis accounts for the absence or marked reduction of immunoprotection induced by inviable or glutaraldehyde-treated cells, isolated cell membranes and soluble tumour extracts which retain serologically defined tumour-specific antigens.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375964      PMCID: PMC2009978          DOI: 10.1038/bjc.1979.114

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Cell-mediated immune response in vitro. IV. Metabolic studies on cellular immunogenicity.

Authors:  H Wagner
Journal:  Eur J Immunol       Date:  1973-02       Impact factor: 5.532

2.  An association between actin and the major histocompatibility antigen H-2.

Authors:  G L Koch; M J Smith
Journal:  Nature       Date:  1978-05-25       Impact factor: 49.962

Review 3.  T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity.

Authors:  H Wagner; M Röllinghoff; G J Nossal
Journal:  Transplant Rev       Date:  1973

4.  Cross-linked surface Ig attaches to actin.

Authors:  J Flanagan; G L Koch
Journal:  Nature       Date:  1978-05-25       Impact factor: 49.962

5.  Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.

Authors:  M R Price; R W Baldwin
Journal:  Int J Cancer       Date:  1977-08-15       Impact factor: 7.396

Review 6.  Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1976-04-30

7.  Modification of the immunogenicity and antigenicity of rat hepatoma cells. I. Cell-surface stabilization with glutaraldehyde.

Authors:  M R Price; R G Dennick; R A Robins; R W Baldwin
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640

8.  Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata.

Authors:  R W Baldwin; C R Barker
Journal:  Br J Cancer       Date:  1967-12       Impact factor: 7.640

9.  Immunogenic properties of rat hepatoma subcellular fractions.

Authors:  M R Price; R W Baldwin
Journal:  Br J Cancer       Date:  1974-11       Impact factor: 7.640

  9 in total
  3 in total

1.  Modification of the immunogenicity and antigenicity of rat hepatoma cells. I. Cell-surface stabilization with glutaraldehyde.

Authors:  M R Price; R G Dennick; R A Robins; R W Baldwin
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640

2.  Effect of heat and glutaraldehyde upon the immunogenicity of Meth A sarcoma cells.

Authors:  M R Price; R G Dennick; L W Law
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640

3.  Non-immunogenicity of enucleated rat hepatoma cells in syngeneic animals.

Authors:  D Gerlier; M Price; R W Baldwin
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.